CA2326528A1 - Cholesterol sulfate compositions for artificial skin tanning - Google Patents

Cholesterol sulfate compositions for artificial skin tanning Download PDF

Info

Publication number
CA2326528A1
CA2326528A1 CA002326528A CA2326528A CA2326528A1 CA 2326528 A1 CA2326528 A1 CA 2326528A1 CA 002326528 A CA002326528 A CA 002326528A CA 2326528 A CA2326528 A CA 2326528A CA 2326528 A1 CA2326528 A1 CA 2326528A1
Authority
CA
Canada
Prior art keywords
cholesterol sulfate
artificial skin
skin tanning
sulfate compositions
desquamation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002326528A
Other languages
French (fr)
Other versions
CA2326528C (en
Inventor
Daniel H. Maes
Kenneth D. Marenus
Christina G. Fthenakis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Color Access Inc
Original Assignee
Color Access, Inc.
Daniel H. Maes
Kenneth D. Marenus
Christina G. Fthenakis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Color Access, Inc., Daniel H. Maes, Kenneth D. Marenus, Christina G. Fthenakis filed Critical Color Access, Inc.
Publication of CA2326528A1 publication Critical patent/CA2326528A1/en
Application granted granted Critical
Publication of CA2326528C publication Critical patent/CA2326528C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Abstract

The present invention provides a method of retarding desquamation of the stratum corneum, and maintaining stratum corneum thickness, by applying to the skin an effective amount of cholesterol sulfate.
The retardation of desquamation can be useful in enhancing the skin's own UV protection, in prolonging the retention time of a sunless tan, and generally reducing the appearance of lines and wrinkles associated with both photo- and chronoaging.
CA002326528A 1999-02-08 2000-02-02 Cholesterol sulfate compositions for artificial skin tanning Expired - Lifetime CA2326528C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/246,607 US20020098207A1 (en) 1999-02-08 1999-02-08 Cholesterol sulfate compositions for enhancement of stratum corneum function
US09/246,607 1999-02-08
PCT/US2000/002750 WO2000045786A1 (en) 1999-02-08 2000-02-02 Cholesterol sulfate compositions for enhancement of stratum corneum function

Publications (2)

Publication Number Publication Date
CA2326528A1 true CA2326528A1 (en) 2000-08-10
CA2326528C CA2326528C (en) 2005-08-02

Family

ID=22931385

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002326528A Expired - Lifetime CA2326528C (en) 1999-02-08 2000-02-02 Cholesterol sulfate compositions for artificial skin tanning

Country Status (11)

Country Link
US (2) US20020098207A1 (en)
EP (1) EP1069883B1 (en)
JP (1) JP3842558B2 (en)
KR (1) KR100667124B1 (en)
AT (1) ATE526944T1 (en)
AU (1) AU756361B2 (en)
CA (1) CA2326528C (en)
ES (1) ES2372805T3 (en)
HK (1) HK1033912A1 (en)
WO (1) WO2000045786A1 (en)
ZA (1) ZA200005413B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003528904A (en) 2000-04-04 2003-09-30 カラー アクセス,インコーポレイティド Composition for improving skin lipid barrier function
US20020142013A1 (en) * 2001-01-31 2002-10-03 Maes Daniel H. Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
EP1377258A2 (en) * 2001-03-30 2004-01-07 L'oreal Heat activated durable conditioning compositions comprising saccharides and methods for using the same
DE10155200A1 (en) * 2001-11-12 2003-05-28 Skinlab Gmbh Use of cholesterol, substances containing cholesterol or substances that increase cholesterol in cosmetic and dermatological preparations for the purpose of UV protection
FR2833166B1 (en) * 2001-12-07 2004-08-27 Oreal SELF-TANNING COMPOSITION CONTAINING AN AMINOSUBSTITUTED 2-HYDROXYBENZOPHENONE DERIVATIVE AND A SELF-TANNING AGENT
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
EP2108370A1 (en) 2002-04-30 2009-10-14 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
AU2004228021B2 (en) 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
EP1703891A1 (en) * 2003-12-11 2006-09-27 MERCK PATENT GmbH Method of tanning human body by mysting or immersion at elevated temperature
GB2413763A (en) * 2004-05-04 2005-11-09 Lifestyle Beauty Ltd Composition for application to skin
US20070059269A1 (en) * 2005-08-17 2007-03-15 L'oreal Administration of 8-hexadecene-1,16-dicarboxylic acid for promoting cohesion of the epidermal horny layer
EP2074985B1 (en) * 2006-08-11 2013-07-03 Toyobo Co., Ltd. Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof
US9289373B2 (en) 2009-10-26 2016-03-22 International Flora Technologies, Ltd. Human sebum mimetics derived from botanical sources and methods for making the same
WO2015095010A2 (en) * 2013-12-18 2015-06-25 International Flora Technologies, Ltd. Human sebum mimetics derived from botanical sources and methods for making the same
PL3125865T3 (en) * 2014-04-04 2019-10-31 Unifarco S P A Association of active ingredients for topical use in restructuring altered cutaneous barrier following to cutaneous diseases
JP7008328B2 (en) * 2015-11-20 2022-01-25 国立大学法人九州大学 Immune regulator

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161911A (en) * 1984-01-31 1985-08-23 Kanebo Ltd Skin cosmetic
US5084270A (en) * 1988-04-22 1992-01-28 Revlon, Inc. Cosmetic compositions containing N-alkoxyalkylamides
US5508034A (en) * 1988-08-12 1996-04-16 Genderm Corporation Method and composition for treating and preventing dry skin disorders
AU4216089A (en) * 1988-08-12 1990-03-05 Joel E. Bernstein Method and composition for treating and preventing dry skin disorders
ZA901675B (en) * 1989-03-07 1990-11-28 Plough Liposome compositions
JPH0551314A (en) * 1991-08-20 1993-03-02 Kanebo Ltd Skin cosmetics
FR2694289B1 (en) * 1992-07-29 1994-10-14 Oreal Sulfur, fluorinated and polyglycerolated amphiphilic compounds, cosmetic or pharmaceutical composition comprising them, process for preparation and vesicles formed.
FR2716622B1 (en) * 1994-02-28 1996-04-12 Oreal Cosmetic self-tanning compositions based on dihydroxyacetone, process for preparation and use.
FR2727626B1 (en) * 1994-12-05 1997-01-17 Oreal SELF-TANNING COSMETIC COMPOSITIONS BASED ON DIHYDROXYACETONE, ALKYLPOLYOSIDES AND FATTY ALCOHOLS
US5705145A (en) * 1996-08-21 1998-01-06 E-L Management Corp. Skin tanning compositions and method
DE19642872C1 (en) * 1996-10-17 1998-02-12 Henkel Kgaa Use of sterol sulphate compounds to inhibit serine protease
JPH115742A (en) * 1997-04-21 1999-01-12 Shiseido Co Ltd External preparation containing cholesterol sulfate
DE19834812A1 (en) * 1998-08-01 2000-02-03 Beiersdorf Ag Use of sterol derivatives, e.g., dihydrocholesterol, to strengthen the barrier function of skin, e.g., to protect against drying of skin and associated skin aging

Also Published As

Publication number Publication date
JP3842558B2 (en) 2006-11-08
CA2326528C (en) 2005-08-02
ZA200005413B (en) 2001-06-04
AU756361B2 (en) 2003-01-09
WO2000045786A1 (en) 2000-08-10
ES2372805T3 (en) 2012-01-26
ATE526944T1 (en) 2011-10-15
KR20010042530A (en) 2001-05-25
HK1033912A1 (en) 2001-10-05
AU2753400A (en) 2000-08-25
EP1069883B1 (en) 2011-10-05
KR100667124B1 (en) 2007-01-12
JP2002536313A (en) 2002-10-29
US20020098207A1 (en) 2002-07-25
EP1069883A1 (en) 2001-01-24
US20040028639A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
CA2326528A1 (en) Cholesterol sulfate compositions for artificial skin tanning
AU4157397A (en) Compositions and methods for skin tanning and protection
WO2000057900A3 (en) Factor for regulation of neurite growth
CA2441025A1 (en) Composition containing feverfew extract and use thereof
AU5377596A (en) Film forming foundation
HUP9801175A3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
NZ504076A (en) A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
ZA964552B (en) Compositions for topical application to skin.
AU3986795A (en) Succinic acid derivatives and their use as surfactants
NZ330967A (en) Composition and treatment of skin wrinkles containing dibutyl adipate and isopropyl myristate and no effective amount of a recognised active agent
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
CA2306040A1 (en) Coloring agent-containing sunless tanning compositions
EP2020228A3 (en) Skin cosmetic composition
AU1844197A (en) Skin smoothing compositions containing hydroxyacids and methods for using same
AU3637293A (en) Cosmetic composition containing melanistic pigments in association with certain tocopherols, and method for protecting the skin, the hair, the mucous membranes and cosmetic compositions
AU5792399A (en) Stable ascorbic acid preparation for topical use
AU5727796A (en) Methods to inhibit late radiation-induced skin damage
AU1784301A (en) Topical skin composition
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
CA2355955A1 (en) Skin lightening composition
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
AU5988896A (en) Topical composition for fungal treatment
NZ305571A (en) Cryptophycin derivatives, use in pharmaceutical compositions to inhibit mammalian cell proloferation and treat neoplasia
CA2275167A1 (en) The topical use of kappa opioid agonists to treat ocular pain

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200203